As prevention trials for Alzheimer’s disease ramp up, researchers need fast and cheap ways to diagnose early, and to screen cognitively normal people. PET is expensive. Cerebrospinal fluid (CSF) ...

The second question, is does any additional diagnostic accuracy provided by the CSF test matter? In clinical practice, a laboratory test that confirmed Alzheimer's disease would remove ambiguity in ...

A laboratory technician holds a blood sample in Germany. Photographer: Krisztian Bocsi/Bloomberg Senior Correspondent As the world’s population ages, health experts are bracing for higher rates of age ...

Add Yahoo as a preferred source to see more of our stories on Google. As of 2023, an estimated 6.7 million Americans aged 65 and older were living with Alzheimer’s disease, according to the ...

Roche is on a roll: For the second time in less than a year, the company has scored FDA clearance for a pair of assays that can be used together to help spot signs of Alzheimer’s disease. The duo ...